Nanostructure-Drug Conjugates
OwnerLon J. Wilson, Michael G. Rosenbluminventors
Life of this patent
Estimating the term…
Abstract
Nanostructure-drug conjugates and associated methods of use are provided. In one embodiment, a nanostructure-drug conjugate comprising a Cn, a crosslinker, and a drug is provided, wherein Cn refers to a fullerene moiety or nanotube comprising n carbon atoms. A method of treating cancer is also provided, comprising administering a therapeutically effective amount of a nanostructure-drug conjugate comprising: a Cn, a crosslinker, and a drug, wherein Cn refers to a fullerene moiety comprising n carbon atoms to a mammal.
Claims12
A nanostructure-drug conjugate comprising:
- a Cn, a crosslinker, and a drug, wherein Cn refers to a fullerene moiety or nanotube comprising n carbon atoms.
A method of treating cancer comprising administering a therapeutically effective amount of a nanostructure-drug conjugate comprising:
- a Cn, a crosslinker, and a drug, wherein Cn refers to a fullerene moiety comprising n carbon atoms to a mammal.
Dependencies are inferred from the claim text.